MyCare - Patients: View your medical records securely online here.
Log in Learn More

A phase III, multicenter, randomized, double-blind, placebo-controlled study to evaluate the effectiveness of the drug Lixivaptan in normalizing serum sodium concentrations up to 28 days in people with hyponatremia.

IRB Number: N/A
Status: Not Enrolling
Start Date: November 01, 2009
Principal Name: Richard Sterns, MD
Contact Name: Tia DeRosa, NP, Office for Clinical Research
Phone: (585) 922-3536